Co Incidence of Microcytic Anemia with other Chronic Diseases like Diabetes, Hypertension and Ischemic Heart Disease in Patients at PAF Hospital Islamabad
DOI:
https://doi.org/10.70749/ijbr.v3i6.2189Keywords:
Microcytic anemia, Diabetes mellitus, Hypertension, Ischemic heart disease.Abstract
Background: Microcytic anemia is a frequent hematological disorder that frequently accompanies chronic non-communicable diseases and may exacerbate morbidity and affect the progression of these diseases. Although clinically important, little local information is available regarding the prevalence of microcytic anemia in diabetes mellitus, hypertension, and ischemic heart disease patients. Objective: To determine the frequency and association of microcytic anemia with diabetes mellitus, hypertension, and ischemic heart disease in adult patients. Study Design: Descriptive cross-sectional study. Duration and Place of Study: The study was conducted from August 2024 to January 2025 at the Department of Medicine, PAF Hospital, Islamabad. Methodology: A total of 252 adult patients with confirmed diagnoses of diabetes mellitus, hypertension, or ischemic heart disease were enrolled. Exclusion criteria included other known causes of anemia, recent transfusion, hematological malignancies, and advanced liver disease. Data collection involved demographic details, medical history, clinical records, and laboratory investigations. Microcytic anemia was defined according to World Health Organization criteria using mean corpuscular volume and hemoglobin levels. Results: The mean age of participants was 55.67 ± 10.97 years, with 135 males (53.6%) and 117 females (46.4%). Overall, 110 patients (43.7%) had microcytic anemia. Among diabetics, anemia was present in 63 (44.1%) versus 47 (43.1%) in non-diabetics (p=0.882). In hypertensive patients, anemia was significantly more frequent (75, 52.1%) compared to non-hypertensives (35, 32.4%) (p=0.002). In ischemic heart disease, anemia was found in 33 (50.8%) compared to 77 (41.2%) without the disease (p=0.179). Correlation analysis showed hypertension duration had significant negative correlations with hemoglobin (r=-0.137, p<0.05) and mean corpuscular volume (r=-0.223, p<0.01). Conclusion: Microcytic anemia is common among patients with chronic diseases, with hypertension showing a significant association.
Downloads
References
1. Kuang L, Li W, Xu G, You M, Wu W, Li C. Systematic review and meta-analysis: influence of iron deficiency anemia on blood glycosylated hemoglobin in diabetic patients. Ann Palliat Med. 2021;10(11):11876-11885.
https://doi.org/10.21037/apm-21-2944.
2. Shwetha MS, Manu B, Shashidharan P, Deepika T, Kora SA. Effect of iron deficiency anemia on glycosylated hemoglobin levels in non-diabetics: a case control study. Eur J Cardiovasc Med. 2024;14(6):581-586.
3. Mazumder H, Islam KF, Rahman F, Gain EP, Saha N, Eva IS, et al. Prevalence of anemia in diabetes mellitus in South Asia: a systematic review and meta-analysis. PLoS One. 2023;18(5):e0285336
https://doi.org/10.1371/journal.pone.0285336.
4. Subramaniam SK, Umashankar R, Vinatha MC, Raj A, The K, Keerthana I, et al. Prevalence of nutritional anaemia in type 2 diabetes mellitus in the absence of renal impairment. Cureus. 2024;16(11):e72946.
https://doi.org/10.7759/cureus.72946.
5. Gela YY, Belay DG, Chilot D, Andualem AA, Bitew DA, Sinamaw D, et al. Prevalence of anemia and associated factors among adult hypertensive patients in referral hospitals, Amhara Regional State. Sci Rep. 2023;13(1):14329.
https://doi.org/10.1038/s9999-023-41553-z.
6. Sawicki KT, De Jesus A, Ardehali H. Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets. Circ Res. 2023;132(3):328-347.
https://doi.org/10.1161/CIRCRESAHA.122.321667.
7. Zeidman A, Fradin Z, Blecher A, Oster HS, Avrahami Y, Mittelman M. Anemia as a risk factor for ischemic heart disease. Isr Med Assoc J. 2004 Jan;6(1):16-8.
8. Fallon J. Iron deficiency and treatment for cardiovascular disease: key points. American College of Cardiology. 2022.
https://www.acc.org/Latest-in-Cardiology/ten-points- toremember/2022/11/30/17/14/iron-deficiency-and-cvd
9. Misiewicz A, Badura K, Matuszewska-Brycht O, Krekora J, Drożdż J. Iron deficiency as a factor of worse prognosis in patients with acute myocardial infarction. Biomedicines. 2025;13(4):769.
https://doi.org/10.3390/biomedicines13040769.
10. Savarese G, von Haehling S, Butler J, Cleland JG, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J. 2023;44(1):14-29.
https://doi.org/10.1093/eurheartj/ehac562241.
11. Stucchi M, Cantoni S, Piccinelli E, Somaschini A, Senni M. Anemia and acute coronary syndrome: current perspectives. Vasc Health Risk Manag. 2018;14:157-167.
https://doi.org/10.2147/VHRM.S140951.
12. Yetman D. Anemia and hypertension: can one lead to the other? Healthline. 2025. https://www.healthline.com/health/anemia-with-hypertension
13. Lanser L, Fuchs D, Scharnagl H, Grammer T, Kleber ME, Marz W, et al. Anemia of chronic disease in patients with cardiovascular disease. Front Cardiovasc Med. 2021;8:666638.
https://doi.org/10.3389/fcvm.2021.666638.
14. Dhungel S, Gautam S, KC B, Khan M, Shakya A, Bhattarai P, et al. Pattern of anemia in patients with heart failure in ischemic heart disease. JNHLS. 2024;3(2):63-68.
15. Barbieri J, Fontela PC, Winkelmann ER, et al. Anemia in patients with type 2 diabetes mellitus. Anemia. 2015;2015:354737.
https://doi.org/10.1155/2015/354737.
16. Tegene E, Mohammed A, Godebo T, et al. Prevalence of anemia and associated factors in patients with heart failure admitted to Jimma University Medical Center. BMC Cardiovasc Disord. 2025;25:253.
https://doi.org/10.1186/s12872-025-04714-8.
17. Kumar M, Pankaj SK, Mishra A, Jaiswal CP. A hospital-based study to determine the specific aetiology of microcytic anemia. Int J Curr Pharm Rev Res. 2024;16(4):584-590.
18. Ikram N, Baqai HZ, Hassan K. Anemia of chronic diseases. J Islamabad Med Dent Coll. 2012;2:89-92.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
